lenalidomide maintenance in mm: data update
Published 4 years ago • 55 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:07
lenalidomide maintenance – an active approach to treating mm?
-
1:30
the impact of lenalidomide maintenance therapy on myeloma patients in the uk
-
1:22
maintenance therapy in mm: perspectives
-
2:02
evaluating the optimal duration of lenalidomide maintenance after autosct using data from myeloma xi
-
2:00
sustained mrd negativity in mm with lenalidomide maintenance
-
11:27
jesús san miguel: is myeloma curable?
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
9:39
myeloma for beginners - treatment and treatment decisions
-
1:25
lenalidomide maintenance remains best for newly diagnosed mm
-
1:45
long-term findings from mcl0208: lenalidomide maintenance post autosct in mcl
-
8:40
lenalidomide, mutations & mds outcomes
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
1:06
lenalidomide: should maintenance therapy after autograft be limited?
-
1:12
the impact of lenalidomide on second primary malignancies: long-term data from the myeloma xi trial
-
0:45
majestec-2 update: teclistamab plus lenalidomide in r/r multiple myeloma
-
1:35
the impact of frontline maintenance therapy on myeloma patients in the uk
-
2:21
lenalidomide maintenance therapy in patients with multiple myeloma and high-risk cytogenetics
-
4:55
long-term outcomes of vrd, auto-hct with mel200 conditioning & lenalidomide maintenance in mm
-
2:24
myeloma: lenalidomide maintenance therapy
-
1:45
latest updates on maintenance therapy in myeloma
-
1:13
majestec-4: teclistamab lenalidomide vs lenalidomide as maintenance therapy in ndmm